Methylphenidate Hydrochloride
- Product NDC
- 62175-312
- 11-digit product format
- 621750312
- Labeler code
- 62175
- Product ID
- 62175-312_8b133cd2-e3c6-4742-b402-2393b56ffc93
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methylphenidate Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA091695
- Marketing category
- ANDA
- Marketing start
- 2013-09-23
- Substance
- METHYLPHENIDATE HYDROCHLORIDE
- Active strength
- 36 mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methylphenidate Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHYLPHENIDATE HYDROCHLORIDE | 36 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4B3SC438HI |
| Rxcui | 2001564, 2001565, 2001566, 2001568 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62175-312-37 | Methylphenidate Hydrochloride | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 32 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| METHYLPHENIDATE HYDROCHLORIDE | ACTIVE INGREDIENT | 4B3SC438HI | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| METHYLPHENIDATE | ACTIVE MOIETY | 207ZZ9QZ49 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 400 MPA.S AT 1%) | INACTIVE INGREDIENT | FC40A8XAJ3 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| ETHYLCELLULOSE (10 MPA.S) | INACTIVE INGREDIENT | 3DYK7UYZ62 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S) | INACTIVE INGREDIENT | 6N003M473W | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 17 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62175-312 | METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [LANNETT COMPANY, INC.] | 28 | Current NDC, Legacy NDC, 1 package rows | 20241025_3d1f5aff-5d39-496c-b5ed-7f3c70ec641c.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 2001566 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | cd2c1226-fa19-4734-b62d-89fea73dcb0d | 102 |
| 2001566 | BX Rating 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet | SCD | cd2c1226-fa19-4734-b62d-89fea73dcb0d | 102 |
| 2001566 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | SY | cd2c1226-fa19-4734-b62d-89fea73dcb0d | 102 |
| 2001564 | methylphenidate HCl 18 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001565 | methylphenidate HCl 27 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001566 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001568 | methylphenidate HCl 54 MG 24HR Extended Release Oral Tablet, BX Rating | PSN | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001564 | BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet | SCD | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001565 | BX Rating 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet | SCD | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001566 | BX Rating 24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet | SCD | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001568 | BX Rating 24 HR methylphenidate hydrochloride 54 MG Extended Release Oral Tablet | SCD | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001564 | methylphenidate HCl 18 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001565 | methylphenidate HCl 27 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001566 | methylphenidate HCl 36 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
| 2001568 | methylphenidate HCl 54 MG 24HR Extended Release Oral Tablet, BX Rating | SY | 3d1f5aff-5d39-496c-b5ed-7f3c70ec641c | 32 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62175-312-37 | 62175031237 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-312-37) | 2013-09-23 | 0000-00-00 | No | No | Current |